Steven Cohen's ANGO Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 3.18 M shares of AngioDynamics, Inc. (ANGO) worth $36.18 M, representing 0.05% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 22 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in ANGO, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 1.02 M shares. Largest reduction occurred in Q4 2022, reducing 517,346 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's AngioDynamics (ANGO) Holding Value Over Time
Track share changes against reported price movement
Quarterly AngioDynamics (ANGO) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +356,330 | Add 12.61% | 3.18 M | $11.37 |
| Q4 2025 | +266,697 | Add 10.42% | 2.83 M | $12.84 |
| Q3 2025 | +609,906 | Add 31.29% | 2.56 M | $11.17 |
| Q2 2025 | +1.02 M | Add 109.86% | 1.95 M | $9.92 |
| Q1 2025 | +928,657 | New Buy | 928,657 | $9.39 |
| Q2 2024 | -360,442 | Sold Out | 0 | $0.00 |
| Q1 2024 | +358,342 | Add 17063.90% | 360,442 | $5.87 |
| Q4 2023 | -323,541 | Reduce 99.36% | 2,100 | $7.84 |
| Q3 2023 | -110,313 | Reduce 25.30% | 325,641 | $7.31 |
| Q2 2023 | +321,454 | Add 280.75% | 435,954 | $10.43 |
| Q1 2023 | -25,254 | Reduce 18.07% | 114,500 | $10.34 |
| Q4 2022 | -517,346 | Reduce 78.73% | 139,754 | $13.77 |
| Q3 2022 | -270,103 | Reduce 29.13% | 657,100 | $20.46 |
| Q2 2022 | -218,067 | Reduce 19.04% | 927,203 | $19.35 |
| Q1 2022 | +366,916 | Add 47.14% | 1.15 M | $21.54 |
| Q4 2021 | +420,822 | Add 117.70% | 778,354 | $27.58 |
| Q3 2021 | -359,704 | Reduce 50.15% | 357,532 | $25.94 |
| Q2 2021 | +286,427 | Add 66.49% | 717,236 | $27.13 |
| Q1 2021 | +64,920 | Add 17.74% | 430,809 | $23.40 |
| Q4 2020 | +365,889 | New Buy | 365,889 | $15.33 |
| Q3 2014 | -41,300 | Sold Out | 0 | $0.00 |
| Q2 2014 | +41,300 | Add 0.00% | 41,300 | $16.32 |
Steven Cohen's AngioDynamics Investment FAQs
Steven Cohen first purchased AngioDynamics, Inc. (ANGO) in Q2 2014, acquiring 41,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held AngioDynamics, Inc. (ANGO) for 22 quarters since Q2 2014.
Steven Cohen's largest addition to AngioDynamics, Inc. (ANGO) was in Q2 2025, adding 1,948,896 shares worth $19.33 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 3,181,829 shares of AngioDynamics, Inc. (ANGO), valued at approximately $36.18 M.
As of the Q1 2026 filing, AngioDynamics, Inc. (ANGO) represents approximately 0.05% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in AngioDynamics, Inc. (ANGO) was 3,181,829 shares, as reported at the end of Q1 2026.